Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Your locks will thank you
16: e61951 doi: 10.7759/cureus.61951
GH Secretagogue Comparison Compound Class Receptor FDA Status Ipamorelin GHRP (ghrelin mimetic) GHS-R1a Not approved CJC-1295 GHRH analog GHRH-R Not approved Sermorelin GHRH analog GHRH-R Previously approved (Geref, discontinued) Tesamorelin GHRH analog GHRH-R FDA approved (Egrifta) GHRP-2 GHRP (ghrelin mimetic) GHS-R1a Not approved GHRP-6 GHRP (ghrelin mimetic) GHS-R1a Not approved Selectivity Profile: The Key Research Differentiator What makes Ipamorelin stand out among GHRPs is its endocrine selectivity
L-carnitine supplementation ameliorates insulin resistance in critically ill acute stroke patients: a randomized, double-blinded, placebo-controlled clinical trial
Or sign up for a free, 30-minute consultation
